Drug Shortage Report for APO-FROVATRIPTAN

Last updated on 2020-06-29 History
Report ID 80264
Drug Identification Number 02426471
Brand name APO-FROVATRIPTAN
Common or Proper name Frovatriptan
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) FROVATRIPTAN
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-07
Estimated end date 2020-07-03
Actual end date 2020-06-24
Shortage status Resolved
Updated date 2020-06-29
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-06-29 French Compare
v17 2020-06-29 English Compare
v16 2020-06-15 French Compare
v15 2020-06-15 English Compare
v14 2020-05-22 French Compare
v13 2020-05-22 English Compare
v12 2020-04-27 French Compare
v11 2020-04-27 English Compare
v10 2020-02-18 French Compare
v9 2020-02-18 English Compare
v8 2020-02-18 French Compare
v7 2020-02-18 English Compare
v6 2020-01-22 French Compare
v5 2020-01-22 English Compare
v4 2019-10-07 French Compare
v3 2019-10-07 English Compare
v2 2019-04-01 French Compare
v1 2019-04-01 English Compare